PMC:7205724 / 392-561
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 7 | 22-30 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 10 | 35-38 | Gene | denotes | IL6 | Gene:3569 |
| 11 | 107-115 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 17 | 141-144 | Gene | denotes | IL6 | Gene:3569 |
| 20 | 120-131 | Chemical | denotes | Tocilizumab | MESH:C502936 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T3 | 22-30 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T4 | 107-115 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T5 | 2-17 | Chemical | denotes | corticosteroids | http://purl.obolibrary.org/obo/CHEBI_50858 |
LitCovid-sample-MedDRA
| Id | Subject | Object | Predicate | Lexical cue | meddra_id |
|---|---|---|---|---|---|
| T2 | 78-88 | http://purl.bioontology.org/ontology/MEDDRA/10022891 | denotes | viral load | http://purl.bioontology.org/ontology/MEDDRA/10062178 |
LitCovid-sample-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T4 | 2-17 | Chemical | denotes | corticosteroids | http://purl.obolibrary.org/obo/CHEBI_50858 |
LitCovid-sample-PD-NCBITaxon
| Id | Subject | Object | Predicate | Lexical cue | ncbi_taxonomy_id |
|---|---|---|---|---|---|
| T3 | 22-30 | Species | denotes | COVID-19 | NCBItxid:2697049 |
| T4 | 107-115 | Species | denotes | COVID-19 | NCBItxid:2697049 |
LitCovid-sample-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T8 | 32-116 | Sentence | denotes | • IL6 correlates with severity, criticality, viral load, and prognosis of COVID-19. |
LitCovid-sample-Pubtator
| Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
|---|---|---|---|---|---|
| 7 | 22-30 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 10 | 35-38 | Gene | denotes | IL6 | Gene:3569 |
| 11 | 107-115 | Disease | denotes | COVID-19 | MESH:C000657245 |
| 20 | 120-131 | Chemical | denotes | Tocilizumab | MESH:C502936 |
| 17 | 141-144 | Gene | denotes | IL6 | Gene:3569 |
LitCovid-sample-UniProt
| Id | Subject | Object | Predicate | Lexical cue | uniprot_id |
|---|---|---|---|---|---|
| T1 | 35-38 | Protein | denotes | IL6 | https://www.uniprot.org/uniprot/Q9XT80|https://www.uniprot.org/uniprot/Q9UCU4|https://www.uniprot.org/uniprot/Q9UCU3|https://www.uniprot.org/uniprot/Q9UCU2|https://www.uniprot.org/uniprot/Q9MZR1|https://www.uniprot.org/uniprot/Q9MYZ7|https://www.uniprot.org/uniprot/Q95KN6|https://www.uniprot.org/uniprot/Q95181|https://www.uniprot.org/uniprot/Q90YI0|https://www.uniprot.org/uniprot/Q8MKH0|https://www.uniprot.org/uniprot/Q8BN26|https://www.uniprot.org/uniprot/Q865X6|https://www.uniprot.org/uniprot/Q865W7|https://www.uniprot.org/uniprot/Q6V919|https://www.uniprot.org/uniprot/Q6L6X6|https://www.uniprot.org/uniprot/Q5I6E3|https://www.uniprot.org/uniprot/Q3UCQ0|https://www.uniprot.org/uniprot/Q2MH06|https://www.uniprot.org/uniprot/Q28819|https://www.uniprot.org/uniprot/Q28747|https://www.uniprot.org/uniprot/Q28319|https://www.uniprot.org/uniprot/Q25BC2|https://www.uniprot.org/uniprot/Q0PW36|https://www.uniprot.org/uniprot/Q0GGL7|https://www.uniprot.org/uniprot/Q08DT2|https://www.uniprot.org/uniprot/P79341|https://www.uniprot.org/uniprot/P51494|https://www.uniprot.org/uniprot/P46650|https://www.uniprot.org/uniprot/P41693|https://www.uniprot.org/uniprot/P41683|https://www.uniprot.org/uniprot/P41323|https://www.uniprot.org/uniprot/P29455|https://www.uniprot.org/uniprot/P26893|https://www.uniprot.org/uniprot/P26892|https://www.uniprot.org/uniprot/P20607|https://www.uniprot.org/uniprot/P08505|https://www.uniprot.org/uniprot/P05231|https://www.uniprot.org/uniprot/O46568|https://www.uniprot.org/uniprot/O35736|https://www.uniprot.org/uniprot/O19007|https://www.uniprot.org/uniprot/B6CKP4|https://www.uniprot.org/uniprot/A9QWQ9|https://www.uniprot.org/uniprot/A3FBE9|https://www.uniprot.org/uniprot/A0S0B0 |
| T45 | 141-144 | Protein | denotes | IL6 | https://www.uniprot.org/uniprot/Q9XT80|https://www.uniprot.org/uniprot/Q9UCU4|https://www.uniprot.org/uniprot/Q9UCU3|https://www.uniprot.org/uniprot/Q9UCU2|https://www.uniprot.org/uniprot/Q9MZR1|https://www.uniprot.org/uniprot/Q9MYZ7|https://www.uniprot.org/uniprot/Q95KN6|https://www.uniprot.org/uniprot/Q95181|https://www.uniprot.org/uniprot/Q90YI0|https://www.uniprot.org/uniprot/Q8MKH0|https://www.uniprot.org/uniprot/Q8BN26|https://www.uniprot.org/uniprot/Q865X6|https://www.uniprot.org/uniprot/Q865W7|https://www.uniprot.org/uniprot/Q6V919|https://www.uniprot.org/uniprot/Q6L6X6|https://www.uniprot.org/uniprot/Q5I6E3|https://www.uniprot.org/uniprot/Q3UCQ0|https://www.uniprot.org/uniprot/Q2MH06|https://www.uniprot.org/uniprot/Q28819|https://www.uniprot.org/uniprot/Q28747|https://www.uniprot.org/uniprot/Q28319|https://www.uniprot.org/uniprot/Q25BC2|https://www.uniprot.org/uniprot/Q0PW36|https://www.uniprot.org/uniprot/Q0GGL7|https://www.uniprot.org/uniprot/Q08DT2|https://www.uniprot.org/uniprot/P79341|https://www.uniprot.org/uniprot/P51494|https://www.uniprot.org/uniprot/P46650|https://www.uniprot.org/uniprot/P41693|https://www.uniprot.org/uniprot/P41683|https://www.uniprot.org/uniprot/P41323|https://www.uniprot.org/uniprot/P29455|https://www.uniprot.org/uniprot/P26893|https://www.uniprot.org/uniprot/P26892|https://www.uniprot.org/uniprot/P20607|https://www.uniprot.org/uniprot/P08505|https://www.uniprot.org/uniprot/P05231|https://www.uniprot.org/uniprot/O46568|https://www.uniprot.org/uniprot/O35736|https://www.uniprot.org/uniprot/O19007|https://www.uniprot.org/uniprot/B6CKP4|https://www.uniprot.org/uniprot/A9QWQ9|https://www.uniprot.org/uniprot/A3FBE9|https://www.uniprot.org/uniprot/A0S0B0 |
LitCovid-sample-Enju
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T57 | 2-17 | NNS | denotes | corticosteroids |
| T58 | 18-21 | IN | denotes | for |
| T59 | 22-30 | NN | denotes | COVID-19 |
| T60 | 32-33 | LS | denotes | • |
| T61 | 35-38 | NN | denotes | IL6 |
| T62 | 39-49 | VBZ | denotes | correlates |
| T63 | 50-54 | IN | denotes | with |
| T64 | 55-63 | NN | denotes | severity |
| T65 | 63-64 | -COMMA- | denotes | , |
| T66 | 65-76 | NN | denotes | criticality |
| T67 | 76-77 | -COMMA- | denotes | , |
| T68 | 78-83 | JJ | denotes | viral |
| T69 | 84-88 | NN | denotes | load |
| T70 | 88-89 | -COMMA- | denotes | , |
| T71 | 90-93 | CC | denotes | and |
| T72 | 94-103 | NN | denotes | prognosis |
| T73 | 104-106 | IN | denotes | of |
| T74 | 107-115 | NN | denotes | COVID-19 |
| T75 | 117-118 | IN | denotes | • |
| T76 | 120-131 | NNP | denotes | Tocilizumab |
| T77 | 131-132 | -COMMA- | denotes | , |
| T78 | 133-135 | DT | denotes | an |
| T79 | 136-144 | NN | denotes | anti-IL6 |
| T80 | 144-145 | -COMMA- | denotes | , |
| T81 | 146-149 | MD | denotes | can |
| T82 | 150-156 | VB | denotes | confer |
| T83 | 157-164 | NN | denotes | benefit |
| T84 | 165-167 | IN | denotes | in |
| R54 | T59 | T58 | arg2Of | COVID-19,for |
| R55 | T62 | T60 | arg1Of | correlates,• |
| R56 | T61 | T62 | arg1Of | IL6,correlates |
| R57 | T62 | T63 | arg1Of | correlates,with |
| R58 | T71 | T63 | arg2Of | and,with |
| R59 | T64 | T65 | arg1Of | severity,"," |
| R60 | T66 | T65 | arg2Of | criticality,"," |
| R61 | T65 | T67 | arg1Of | ",","," |
| R62 | T69 | T67 | arg2Of | load,"," |
| R63 | T69 | T68 | arg1Of | load,viral |
| R64 | T71 | T70 | arg1Of | and,"," |
| R65 | T67 | T71 | arg1Of | ",",and |
| R66 | T72 | T71 | arg2Of | prognosis,and |
| R67 | T72 | T73 | arg1Of | prognosis,of |
| R68 | T74 | T73 | arg2Of | COVID-19,of |
| R69 | T82 | T75 | arg1Of | confer,• |
| R70 | T76 | T77 | arg1Of | Tocilizumab,"," |
| R71 | T79 | T77 | arg2Of | anti-IL6,"," |
| R72 | T79 | T78 | arg1Of | anti-IL6,an |
| R73 | T82 | T80 | arg1Of | confer,"," |
| R74 | T76 | T81 | arg1Of | Tocilizumab,can |
| R75 | T82 | T81 | arg2Of | confer,can |
| R76 | T76 | T82 | arg1Of | Tocilizumab,confer |
| R77 | T83 | T82 | arg2Of | benefit,confer |
| R78 | T82 | T84 | arg1Of | confer,in |
LitCovid-sample-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T3 | 22-30 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
| T4 | 107-115 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T8 | 32-116 | Sentence | denotes | • IL6 correlates with severity, criticality, viral load, and prognosis of COVID-19. |